Recent developments and outstanding challenges in germ cell tumors
Management of patients with GCT requires a multidisciplinary approach and patients with advanced disease being considered for surgery or those with refractory disease should be referred to a high-volume treatment center. Outcomes in refractory GCT remain poor, but several novel treatment options and approaches are being explored in clinical trials to improve cure rates in this patient population.
Authors
- Tareq Salous (ORCID: https://orcid.org/0000-0002-0455-0013)
- Ahmed Bilal Khalid
Institutions
- Indiana University Health (US)
- Indiana Cancer Consortium (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Current Opinion in Oncology
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1097/cco.0000000000001228
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00